VISTA, an AI-controlled data loop system, guides large-scale antibody design from scratch for applications in cancer therapy.

Sarepta Therapeutics said it will voluntarily “and temporarily” pause all shipments of Elevidys® (delandistrogene ...

Study harnesses a cell-type-specific, multi-target drug discovery strategy grounded in human data and real-world evidence.

Highlights of the Sanner facility include a 60,500-sq-ft site equipped with GMP-certified cleanrooms (ISO class 7 & 8) and ...

An antibody treatment successfully prepared patients for stem cell transplants without toxic chemotherapy or radiation.

Using data from the T2T reference, scientists linked two new genes to changes in brain size and synapse signaling.

IL-1 is considered one of the key mediators involved in the pathogenesis of OA, causing inflammation, joint pain, and ...

Prime editing corrects the most common genetic mutations that cause alternating hemiplegia of childhood (AHC), a rare and severe neurological disorder.

The death of a third patient tied to a Sarepta Therapeutics gene therapy this year sent the company’s shares nosediving 36% ...

A new annotation approach based on cross-species conservation reveals regulatory roles of transposons in human development.

This test can be performed on children before their genetic risk starts to shape their weight, which may support early prevention.

David Baker’s lab has successfully designed binders to disordered proteins, expanding therapeutic access to over 50% of the ...